Doctors’ Knowledge of Hypertension Guidelines Recommendations Reflected in Their Practice
Table 4
Univariate analysis of predictors of CPG adherence.
Variables
CPG adherence (, %)
Odds ratio
95% CI
value
Yes
No
Gender
Male
214 (70.4)
90 (29.6)
Reference
Female
135 (62.5)
81 (36.5)
0.701
0.484–1.014
0.059
Age
Elderly (≥65 years)
127 (65.5)
67 (34.5)
Reference
Nonelderly
222 (68.1)
104 (31.9)
1.126
0.773–1.641
0.536
Comorbidity
No
11 (30.6)
25 (69.4)
Reference
Yes
338 (69.8)
146 (30.2)
5.26
2.52–10.97
0.000
Heart failure
No
277 (64.12)
155 (35.88)
Reference
Yes
72 (81.81)
16 (18.19)
2.209
1.271–3.841
0.005
LVH
No
346 (68.2)
161 (31.6)
Reference
Yes
3 (23.1)
10 (76.9)
0.140
0.038–0.514
0.003
Chronic kidney disease
No
256 (66.3)
130 (33.7)
Reference
Yes
93 (69.4)
41 (30.6)
1.124
0.745–1.698
0.577
Diabetes mellitus
No
188 (66.7)
94 (33.3)
Reference
Yes
161 (67.6)
77 (32.4)
1.068
0.740–1.541
0.725
Dyslipidemia
No
164 (63.3)
95 (36.7)
Reference
Yes
185 (70.9)
76 (29.1)
1.410
0.976–2.037
0.067
Cerebrovascular disease
No
323 (66.5)
163 (33.5)
Reference
Yes
26 (76.5)
8 (23.5)
1.640
0.726–3.703
0.234
Cardiology clinic
No
158 (60.8)
102 (39.8)
Reference
Yes
191 (73.5)
69 (26.5)
1.79
1.23–2.60
0.002
Hypertension clinic
No
317 (72.0)
123 (28.0)
Reference
Yes
32 (40.0)
48 (60.0)
0.26
0.16–0.42
0.004
Nephrology clinic
No
279 (66.4)
141 (33.6)
Reference
Yes
70 (70.0)
30 (30.0)
1.179
0.735–1.893
0.495
Diabetic clinic
No
293 (66.7)
147 (33.3)
Reference
Yes
56 (70.0)
24 (30.0)
1.171
0.698–1.964
0.551
CI, confidence interval; CPG, clinical practice guidelines; LVH, left ventricular hypertrophy. Note. Only statistically significant results are given in the table.
